Close Menu

Going Generic

Pfizer is looking to expand its role in the generics market, reports the Health Blog at the Wall Street Journal. To grow in this market, the president of Pfizer's established products business says they will "develop its own new products, buy licenses or acquire companies." Simmons did not say whether Pfizer was looking into acquiring the Icelandic Actavis Group or the German Ratiopharm, which are both on the market.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.